Westpac Banking Corp’s Novavax NVAX Stock Holding History

Westpac Banking Corp’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-6,013	Closed	-$443K	–	841
2022 Q1	$443K	Hold	6,013	–	–	0.01%	788
2021 Q4	$860K	Hold	6,013	–	–	0.01%	714
2021 Q3	$1.25M	Hold	6,013	–	–	0.01%	684
2021 Q2	$1.28M	Buy	+6,013	New	+$1.1M	0.01%	714

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Westpac Banking Corp's NVAX Position: Q2 2022 in Review

Westpac Banking Corp sold out of Novavax (NVAX) in Q2 2022, closing a stake of 6,013 shares — an estimated $443K sold.

Westpac Banking Corp first reported a position in NVAX in Q2 2021 and held it in 4 quarters. The position peaked at $1.28M in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

Westpac Banking Corp reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
Westpac Banking Corp sold 6,013 Novavax shares in Q2 2022, an estimated $443K.
Westpac Banking Corp first reported a position in Novavax in Q2 2021 and held it in 4 quarters.
Westpac Banking Corp's Novavax position peaked at $1.28M in Q2 2021.
325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Westpac Banking Corp's 13F filing for Q2 2022, filed 10 Aug 2022.